Today, Wednesday, the UAE Ministry of Health announced the registration of a new vaccine against the emerging corona virus (Covid 19), for the Beijing Institute of Biological Products.

According to WAM, the decision to register the vaccine came in response to the request of the Chinese company Sinopharma CNPG, as an expression of the UAE health authorities' confidence in the safety and effectiveness of this vaccine.

>

Health, in cooperation and coordination with the Department of Health in Abu Dhabi, reviewed the preliminary results of the third phase trials conducted by the company, which showed the effectiveness of the vaccine by 86% against infection with the virus.

p>

and seroconversion recorded the rate of 99% of neutralizing antibodies, and 100% as the rate of protection against moderate or severe cases of the disease.

The data also showed that there were no concerns related to the safety of the vaccine for all recipients.

It is reported that the ministry decided last September to provide the vaccine under an emergency use license in order to protect frontline workers, as they are most at risk of infection with Covid 19.

The UAE has studied the clinical results after licensing the emergency use of the safety and efficacy of the vaccine, as ongoing studies have shown results similar to those of the third phase.

The Campaign for Humanity for Phase III trials has succeeded in attracting 31,000 volunteers from 125 nationalities in the UAE, while the experiments of studying the use of the vaccine in emergency situations showed protection for workers in The front lines of the state effectively.

The step of the Ministry of Health and Community Protection to officially register this vaccine produced by the Beijing Institute for Biological Products is a continuation of the march aimed at protecting the entire population of the country, as well as paving the way for re-mobilization Economy wheel.